• E-mail
  • Save
17 Stories on Center for Drug Evaluation and Research
Search this topic

FDA launches program to prevent errors in medication use

The Food and Drug Administration launched an effort Wednesday to reduce needless injuries resulting from preventable medication errors.

FDA wants consumers warned about pain medications

The Food and Drug Administration is requiring makers of painkillers containing propoxyphene, the ingredient in widely used Darvon and Darvocet, to add a warning box to the label highlighting the potential for overdose.

Two anti-smoking drugs to carry mental-health warnings

Two popular anti-smoking drugs will now carry warnings about the risk of severe mental health problems, the Food and Drug Administration announced Wednesday.

FDA requires new labels for over-the-counter painkillers

Over-the-counter painkillers and fever reducers will now carry new labels warning consumers of the potential risks of liver damage and internal bleeding associated with the drugs, according to a final ruling Tuesday by the Food and Drug Administration.

FDA warns makers of unapproved narcotics

Seeking to remove unapproved drugs from the marketplace, the Food and Drug Administration on Tuesday ordered nine companies to stop manufacturing narcotics whose therapeutic claims have not been proved.

Time.com: FDA Posts List of Problem Drugs

The government on Friday began posting a list of prescription drugs under investigation for potential safety problems in an effort to better inform doctors and patients

FDA thinks it has trigger in heparin deaths

New tests suggest how a contaminant in heparin -- a blood thinner -- may be connected to dozens of deaths, FDA officials said Monday.

FDA finds contaminant in suspect blood-thinner

U.S. health officials said Wednesday they have found a contaminant in a blood-thinning drug produced by Baxter Healthcare Corp. that has been linked to more than a dozen deaths in the United States.

FDA panel: No cold medicines to children under 6

Over-the-counter cold and cough medicines don't work for children under age 6, and giving the common medicine to young children cannot be recommended, a Food and Drug Administration advisory committee said in October.

CNNMoney: FDA clears drug for rare growth disease

U.S. health officials have approved an Ipsen drug for treating a rare and potentially life-threatening disease called acromegaly, the Food and Drug Administration said Thursday.

Advertisement
Quick Job Search :
keyword(s):
enter city: